Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1999
10/28/1999CA2328463A1 Matrix binding factor
10/28/1999CA2328435A1 New substituted amides, their production and their use
10/28/1999CA2328430A1 Substituted benzamides, their production and their use as cysteine protease inhibitors
10/28/1999CA2328413A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999CA2328331A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
10/28/1999CA2328264A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/28/1999CA2325864A1 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy
10/28/1999CA2325848A1 B-cell growth factor related protein
10/28/1999CA2325822A1 Soluble protein ztmpo-1
10/28/1999CA2325805A1 Streptococcus preparation
10/28/1999CA2325561A1 Combination therapy using nucleic acids and conventional drugs
10/28/1999CA2323571A1 Novel human k+ ion channel and therapeutic applications thereof
10/28/1999CA2322759A1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments
10/28/1999CA2294980A1 Method for the treatment of endotoxic shock in mammels
10/27/1999EP0952154A2 N-acyl and N-aroyl aralkyl amides
10/27/1999EP0952149A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors
10/27/1999EP0952148A1 Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives
10/27/1999EP0951907A1 Use of moxonidine as a thermogenesis stimulating agent
10/27/1999EP0951906A1 Use of 3,6-dimethyl-2-(2,4,6-trimethylphenoxy)-pyridines for treating heart failure
10/27/1999EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999EP0951553A2 Adenovirus e4 proteins for inducing cell death
10/27/1999EP0951545A2 Human gtp-binding proteins
10/27/1999EP0951540A2 Antisense nucleic acids and hammerhead ribozymes
10/27/1999EP0951536A1 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
10/27/1999EP0951532A1 Bivalent agonists for g-protein coupled receptors
10/27/1999EP0951481A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
10/27/1999EP0951474A1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
10/27/1999EP0951472A1 Peptide compositions with growth factor-like activity
10/27/1999EP0951467A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
10/27/1999EP0951466A2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/27/1999EP0951295A1 Methods and compositions useful for inhibition of angiogenesis
10/27/1999EP0951291A1 Cancer treatment drug
10/27/1999EP0951289A1 $i(MYCOBACTERIUM VACCAE) FOR DOWN-REGULATION OF THE TH2 ACTIVITY OF THE IMMUNE SYSTEM
10/27/1999EP0951285A1 Inhibitors of farnesyl-protein transferase
10/27/1999EP0951281A2 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR
10/27/1999EP0617616B1 Potentiation of nmda antagonists
10/27/1999EP0539525B1 Vitaletheine and use in cell culture and therapy
10/27/1999CN1233256A Dipeptide benzamidine as a kininogenase inhibitor
10/27/1999CN1233254A Purine L-nucleosides, analogs and uses thereof
10/27/1999CN1233246A Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
10/27/1999CN1233243A Crystalline form of 4-[5-methyl-3-phenylisoxazol)-4-yl] benzenesulfonamide
10/27/1999CN1233238A Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
10/27/1999CN1233237A Heteroaryl succinamides and their use as metalloproteinase inhibitors
10/27/1999CN1233182A Citrus peel extract as 3-hydroxy-3-methyl glutaryl-CoA (HMG-CoA) reductase inhibitor
10/27/1999CN1233179A Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
10/27/1999CN1233177A Therapeutic treatment for VEGF related diseases
10/27/1999CN1233176A Substituted tricyclics
10/27/1999CN1233175A Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor
10/27/1999CN1233174A Naringin and naringenin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor
10/27/1999CN1233171A Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin
10/27/1999CN1233150A Method for inhibiting the expression of FAS
10/27/1999CN1232681A Hog cholera treating medicine
10/27/1999CN1232678A Desert cistanche granule
10/27/1999CN1045957C Tricyclic benzazepine, their application and preparation
10/26/1999US5973191 Selective inhibitors of prostaglandin endoperoxide synthase-2
10/26/1999US5973172 14-α,17-α-C2 -bridged norprogesterone derivatives
10/26/1999US5973169 Ipriflavone preparation process
10/26/1999US5973111 Novel compounds that are capable of binding to the active site of interleukin-1b-converting enzyme (ice) and inhibiting activity of that enzyme; administering to treat inflammatory, autoimmune, and neurodegenerative diseases
10/26/1999US5973009 Antioxidant and cytoprotecting activity
10/26/1999US5972990 Administering angiotensin ii inhibitors, such as losartan to patients who are otherwise free of indications for angiotensin ii inhibition treatment and have left ventricular ejection fraction of 40% or less
10/26/1999US5972979 Tricyclic spiro compounds as 5HT1D receptor antagonists
10/26/1999US5972972 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
10/26/1999US5972970 Oxazolidinedione derivatives, their production and use
10/26/1999US5972968 Interleukin inhibitor
10/26/1999US5972965 4,5-diaryl oxazole derivatives
10/26/1999US5972961 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
10/26/1999US5972957 Analgesics and antiarthritic agent
10/26/1999US5972951 Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists
10/26/1999US5972944 Use of thiazolidinedione derivatives in the treatment of anovulation, hyperandrogenism and hirsutism
10/26/1999US5972940 Arginine analogues having nitric oxide synthase inhibitor activity
10/26/1999US5972939 Cyclopentene derivatives useful as antagonists of the motilin receptor
10/26/1999US5972937 Treating central nervous system disorders such as anxiety, depression, epilepsy, obsessive compulsive disorders, migraine, alzheimers disease, sleep disorders, feeding disorders such as anorexia and bulimia, panic attacks
10/26/1999US5972936 Benzofuran carboxamides and their therapeutic use
10/26/1999US5972935 Psychological disordrs, nervous system disorders, parkinson's disorder
10/26/1999US5972928 Administering an antigrowth agent
10/26/1999US5972927 Antiinflammatory, antiallergic and bronchodilatory medicinal products, treatment of asthma
10/26/1999US5972923 Methods and compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants
10/26/1999US5972917 Treatment and prophylaxis of hyperparathyroidism and hyperproliferative diseases, and in the modulation of the immune and inflammatory responses as well as the treatment of bone depletive disorders
10/26/1999US5972913 Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
10/26/1999US5972907 Synthetic core 2-like branched structures containing GalNAc-lewisx and Neu5Acα2-3Galβ1-3GalNAc sequences as novel ligands for selectins
10/26/1999US5972904 Method of treating sinusitis with uridine triphosphates and related compounds
10/26/1999US5972902 DNA encoding human IL-6 receptor antagonist and protein encoded thereby
10/26/1999US5972900 Conjugating target binding moiety consisting of an antibody or fragment which binds to secretory component of polymeric immunoglobulin receptor on surface of epithelium cell, nucleic acid binder, expression vector, compacting, administering
10/26/1999US5972898 Erythromycin a derivatives as lutenizing hormone releasing hormone (lhrh) antagonists, and methods of their preparation
10/26/1999US5972897 Acylated enol derivatives as prodrugs of elastase inhibitors
10/26/1999US5972896 Antiangiogenic peptides and methods for inhibiting angiogenesis
10/26/1999US5972894 Peptides having potassium channel opener activity
10/26/1999US5972698 Tryptase is expressed virtually exclusively by mast cells.
10/26/1999US5972688 HTm4 methods of treatment and assays, agonists and antagonists
10/26/1999US5972680 An aminopeptidase which is involved in insulin regulation.
10/26/1999US5972674 May be used, for example, to identify antibodies and other agents that inhibit or activate signal transduction via the nf-.kappa.b cascade.
10/26/1999US5972649 Polynucleotide sequence encoding human multiple endocrine neoplasia type 1 protein
10/26/1999US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/26/1999US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999CA2183320C Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
10/21/1999WO1999053310A1 Antigen
10/21/1999WO1999053078A2 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
10/21/1999WO1999053077A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999WO1999053076A1 Tao protein kinases and methods of use therefor
10/21/1999WO1999053055A2 Therapeutic agent for ngf
1 ... 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 ... 1564